SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genentech (NYSE:DNA) formerly known as (NYSE:GNE)
An SI Board Since July 1999
Posts SubjectMarks Bans Symbol
250 46 0 DNA
Emcee:  esecurities(tm) Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
75Genentech wins a round in the Cabilly patent dispute: Message 21805213 Cheers,tuck-10/18/2005
74Tarceva adds no benefit to Avastin in metastatic RCC: Message 21802351 Cheers,tuck-10/18/2005
73But they didn't tell us that new info has been added to the label indicatingzeta1961-10/10/2005
72Thanks DD..couldn't listen to entire CC..the Herceptin increase was quite lazeta1961-10/10/2005
71Genentech's Net Rises 56% On Strong U.S. Drug Sales By DAVID P. HAMILTON SDoc Bones-10/10/2005
70Thanks for your notes. Did you hear anything about Tarceva revenue miss being dtuck-10/10/2005
69From an AP update: >>The company also on Monday boosted its expected earntuck-10/10/2005
68Lucentis update: BLA will be submitted in 12/05. It will include two-year MARINDewDiligence_on_SI-10/10/2005
67Avastin penetration in colorectal cancer: 3Q05 penetration in 2nd/3rd-line : 40DewDiligence_on_SI-10/10/2005
66enough for a pop of 4 bucks AH according to Yahoo?zeta1961-10/10/2005
65DNA beats whisper numbers by a penny: >>SOUTH SAN FRANCISCO, Calif., Oct.tuck-10/10/2005
64Link: yahoo.reuters.comQualified Opinion-9/23/2005
63LOL! You may not be totally out of luck. I wouldn't be surprised to see DNCisco-7/21/2005
62no!...I want MRVT to make the big splash with wet Mac Degen! but the odds are prSkywatcher-7/21/2005
61I was thinking short term. I was considering taking a little profit off the tabCisco-7/21/2005
60current target price? Do you mean 6 months, 1 yr, 2 years? The answer is no. keta-7/20/2005
59Do you have a current target price for DNA?Cisco-7/17/2005
58DNA is the company of the future. Aging Boomers getting lotsa cancer and other keta-7/17/2005
57Lucentis story from Tuesday’s WSJ: investorshub.comDewDiligence_on_SI-5/23/2005
56Insider selling, link Link:http://finance.yahoo.com/q/it?s=DNAQualified Opinion-5/23/2005
55According the the ChangeWave Alliance TNKase from Genentech is one of the emergiwellsaid-2/22/2005
54[Phase I Clinical Study of Pertuzumab] >>JCO Early Release, published onltuck-2/8/2005
53really,....had no idea what eom meant. Now Biotech seems to be running up....anDennis-3/7/2004
52Dennis, at the risk that you're pulling my leg, eom is "end of message&fred hayes-3/7/2004
51i know asap....don't know eom......gg....didn't even remember what the hDennis-3/7/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News